Leo director: New recommendation is an important first step
Leo Pharma has won a positive CHMP-recommendation of the biological drug brodalumab – an important milestone in the company’s gamble on biologics “This shows that we take the biological field seriously,” says its R&D chief.
BY ELIZABETH MØNSTED JOHANSEN
Denmark's Leo Pharma has successfully completed the first step in its new venture into the field for biological medicine.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Leo Pharma is still hungry for M&A
For abonnenter
Leo Pharma defeats Teva in patent case
For abonnenter
Leo Pharma launches new company
For abonnenter
